Promoting Mental Health in the Workplace

描述(由申请人提供)：大量研究表明，抑郁症给员工和他们工作的公司带来了沉重的负担。该项目的长期目标是开发一种有效、高效和可持续的干预措施，以减少抑郁症对员工工作能力的不利影响。该项目的主要创新将是由公司已经聘用的员工援助计划(EAP)顾问提供的多模式、以工作为重点的干预计划。它名为工作与健康倡议(WHI)，将为员工提供：1)抑郁症筛查；2)护理活动的协调；3)以工作为重点的认知行为疗法(CBT)策略；以及4)工作修改，以减少抑郁症继发的损害。 总体目标1是评估实施世界卫生倡议的替代战略。该项目将包括：1)使用交叉设计的随机对照试验(RCT)，以测试两种不同的耳朵辅导员培训方法的有效性；2)RCT，比较两种不同的招聘策略，以进行工作场所抑郁症筛查调查；3)雇主访谈，将确定在保护员工隐私的同时报告有关WHI影响的有意义信息的标准。目标1将产生几种产品，这些产品可以为未来工作场所心理健康促进计划的成功做出贡献。这些产品也将被整合到该项目的WHI试验中。 总体目标2是使用随机对照试验设计评估WHI的有效性。洛克希德·马丁公司至少有1.4万名员工，代表着广泛的职业，将有资格完成基于网络的私人抑郁症和工作问题筛查。有抑郁症和工作问题的员工将从筛查中被发现，在面谈和同意之后，一半将被随机分配到常规护理组，一半将被分配到实验WHI组(总计230人)。受试者将在基线和四个月后接受调查。要评估的主要结果是使用有效的工作限制问卷(WLQ)及其缺勤模块评估员工的工作表现和生产率。意向治疗分析将量化WHI对员工工作能力、工作效率和抑郁症状的影响。 WHI可能会帮助患有抑郁症的员工在工作中更有效地运作。此外，这可能会减轻雇主的生产力损失负担。因此，该项目将为包括消费者、购买者、提供者和政策制定者在内的关键卫生保健系统利益攸关方提供重要信息。

DESCRIPTION (provided by applicant): A wealth of research demonstrates that depression places a substantial burden on employees and the firms in which they work. This project's long-term goal is to develop an effective, efficient and sustainable intervention that will reduce depression's adverse impact on the employee's ability to function at work. This project's main innovation will be a multi-modal, work-focused intervention program delivered by employee assistance program (EAP) counselors who companies already employ. Named the Work and Health Initiative (WHI), it will offer employees: 1) depression screening; 2) coordination of care activities; 3) work-focused cognitive behavioral therapy (CBT) strategies; and 4) work modifications to reduce impairments secondary to depression. General Aim 1 is to evaluate alternative strategies for implementing the WHI. This project will include: 1) a randomized controlled trial (RCT), using a crossover design, to test the effectiveness of two different EAR counselor training methods; 2) an RCT comparing two different strategies for recruiting employees into a workplace depression screening survey; 3) employer interviews, which will identify standards for reporting back meaningful information about the impact of the WHI while protecting employee privacy. Aim 1 will generate several products that can contribute to the success of future workplace mental health promotion programs. These products will also be integrated into this project's WHI trial. General Aim 2 is to evaluate the effectiveness of the WHI using an RCT design. At least 14,000 employees of the Lockheed Martin Corporation, representing a wide range of occupations, will be eligible to complete a private, web-based depression and work problem screening. Employees with depression and work problems will be identified from the screening and, following an in-person interview and consent, half will be randomly assigned to the usual care group and half will be assigned to the experimental WHI group (total n=230). Subjects will be surveyed at baseline and four months later. The primary outcomes to be evaluated are employee work performance and productivity using the validated Work Limitations Questionnaire (WLQ) and its work absence module. An intent-to-treat analysis will quantify the impact of the WHI on employee ability to function at work, work productivity, and depression symptoms. The WHI potentially will help employees with depression to function more effectively at work. In addition, it may decrease the burden of productivity loss on employers. Thus, this project will generate important information for key health care system stakeholders including consumers, purchasers, providers, and policymakers.